A Day Up For Acasti Pharma Inc.
Tue, Sep 26, 2023 at 07:59 PM
Acasti Pharma Inc. (ACST:NASDAQ) shot up at $2.41, representing a gain of 37.7%. On Tue, Sep 26, 2023, ACST:NASDAQ touched a New 2-Week High of $2.41. The stock appeared on our News Catalysts scanner on Tue, Sep 26, 2023 at 09:09 AM in the 'PRIVATE PLACEMENT' category. From Tue, Sep 12, 2023, the stock recorded 20.00% Up Days and 36.36% Green Days
About Acasti Pharma Inc. (ACST:NASDAQ)
Acasti Pharma Inc is a biopharmaceutical company. The Company is engaged in the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of cardiometabolic disorders.
Top 10 Gainers:
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 504.97%
- Femasys Inc. (FEMY:NASDAQ), 346.32%
- Signature Bank (SBNY:NASDAQ), 105.88%
- Immunovant, Inc. (IMVT:NASDAQ), 97.04%
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Intercept Pharmaceuticals, Inc. (ICPT:NASDAQ), 79.21%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 64.71%
- DMK Pharmaceuticals Corp Com Par $0.001 (DMK:NASDAQ), 59.25%
- Minerva Surgical Inc. (UTRS:NASDAQ), 55.22%
- Acasti Pharma Inc. (ACST:NASDAQ), 37.71%